Susquehanna International Group, LLP Xenetic Biosciences, Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.31 - $0.73 $16,361 - $38,528	52,779 Added 210.78%	77,819 $31,000
Q4 2022 Feb 14, 2023	BUY	$0.27 - $5.75 $6,760 - $143,980	25,040 New	25,040 $7,000
Q2 2022 Aug 15, 2022	BUY	$0.6 - $1.14 $22,510 - $42,769	37,517 New	37,517 $30,000
Q1 2022 May 16, 2022	SELL	$0.88 - $1.37 $111,859 - $174,144	-127,113 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $2.08 $161,433 - $264,395	127,113 New	127,113 $164,000
Q4 2019 Feb 14, 2020	SELL	$1.05 - $1.66 $17,748 - $28,058	-16,903 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.2 - $12.7 $20,283 - $214,668	16,903 New	16,903 $20,000

Ticker XBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,166,600
Market Cap $65.1M
Description
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.